Bridging funding to enable faster access to medicines in Australia

As a member of the Bridging Funding Coalition, we support the release of a national consensus statement for bridging funding. This would provide earlier, faster, and fairer access to new medicines, bridging the gap between TGA registration and PBS funding, where there is a high unmet need, and patients cannot afford the additional expense and the time to wait for a medicine to be listed on the PBS.

We are calling on the Government to ensure Australian patients get faster access to medicines by committing to establishing bridging funding for medicines; it is wonderful to see an Expert Implementation Group has been established to rapidly co-design a sustainable criteria and model for bridging funding.

Australian patients, their families, and treating clinicians cannot afford the 442 days to make medicines available on the PBS.

The Bridging Funding Coalition now calls on the Government to ensure Australian patients get faster access to medicines by:

  • Committing to establishing bridging funding for medicines, and
  • Establishing an Independent Expert Implementation Group to rapidly co-design a sustainable criteria and model for bridging funding.

Go to www.bridgingfundingaustralia.com.au for more information.

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

A Little Bit Further, The Guy from Goondi fundraiser

Why Your Donation to NeuroEndocrine Cancer Australia Funds Research That Changes Lives

NECA welcomes PBS listing of Selpercatinib for medullary thyroid cancer

NECA Attends Rare Conversations

Our NET Nurses are here to help support you from diagnosis to treatment, and living well with NETs.

Free and confidential, our NET nurses are available Monday – Friday, 9am – 5pm (AEDT).